ONE TWELVE RIVOLI

Brand Owner Address Description
12 RIVOLI 11 HONORE, INC. 8714 Santa Monica Blvd., Suite 201 West Hollywood CA 90069 ONE TWELVE RIVOLI ; TWELVE RIVIOLI;Retail store services featuring clothing, footwear, articles of leather and leather goods, perfumery and cosmetic products, optical goods, articles of fine jewelry and jewelry, stationery items, furniture and household articles, cutlery and crockery products, and games and articles relating to sporting leisure; online retail store services featuring clothing, footwear, articles of leather and leather goods, perfumery and cosmetic products, optical goods, articles of fine jewelry and jewelry, stationery items, furniture and household articles, cutlery and crockery products, and games and articles relating to sporting leisure; advertising and publicity services, namely, promoting the goods, services, brand identity, commercial information, and news of third parties through print, audio, video, digital, and on-line media; fashion show exhibitions for commercial purposes;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The present invention is directed to a method to prevent or reduce postoperative corneal subepithelial haze after excimer laser photorefractive keratectomy (PRK), laser in situ keratomileusis (LASIK) surgery. According to the method, a therapeutically effective amount of one or more plasminogen activators, most preferably urokinase (uPA), is administered topically to the surface of the affected eye at levels between 0.1 and 2,500 IU/ml, about eight to twelve times on the day of surgery, and four to eight times per day for about the next six to twelve days thereafter. The most preferred therapeutic amount is from about 0.1-1 IU uPA/ml, and also 1-10 IU/ml. Plasminogen activators that can be used in the inventions include urokinase, prourokinase, streptokinase and mutants thereof. The invention also covers topical ophthalmic compositions that include one or more plasminogen activators, most preferably uPA, to prevent or reduce postoperative corneal subepithelial haze.